About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
R
Glucagon-like Peptide-1 Receptor Agonist-Based Agents and Weight Loss Composition: Filling the Gaps
By
Robert Dubin
8 views
October 21, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
10:56
Novartis Cardiology
Expert Insights on Pivotal Phase 3 and Long-term Trial Data in Prima…
Feat.
D. G. Karalis,
M. Myerson
Featured Video
04:47
Novartis Cardiology
Examining MOA, Safety, and Efficacy Data for a Non-Statin Lipid-Lowe…
Related Content
AUTOPLAY
ON
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
Feat.
S. Inzucchi
18:43
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century …
Feat.
R. DeFronzo
15:06
Robert Busch
GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!
12:26
Juan Frias
SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide
08:35
Susan Brian
Labs to Check on Semaglutide or Tirzepatide
27:24
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
Feat.
L. Sloan
15:33
Ken Fujioka
Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…
40:48
Michigan Medicine
Incretin-based Therapies in the Management of Obesity and its Comorb…
Feat.
A. Rothberg
26:49
Diana Isaacs
Tirzepatide Updates
07:41
Susan Brian
Weightloss in Menopause
20:24
Diana Isaacs
Tirzepatide for Type 2 Diabetes
06:31
Susan Brian
Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist
05:08
Susan Brian
The Differences Between the Products of GLP1's and GLP/GIPs
26:57
Houston Methodist
Endoscopic Weight Loss Therapies - A Paradigm Shift in the Treatment…
Feat.
T. R. Mccarty
36:34
Scripps Health
GLP-1 Hysteria
Feat.
S. Harris
32:27
Scripps Health
Obesity: A Serious Cardiovascular Risk Factor? A Review of GLP-1 Rec…
Feat.
L. Vincent
04:03
Susan Brian
New Research: Side Effect of GLP1
49:21
McMaster University Department of Medicine
Semaglutide: Where Are We Now and Where Are We Going?
Feat.
S. Boushahri,
D. Lazzam,
K. MacEachern
14:12
Bijin Thajudeen
Management of Kidney Health in CKD and DKD: A Cased-Based Multiple-c…
05:40
Susan Brian
An Introduction to Tirzepatide for Weightloss
